Back
Kura Sushi USA Vs. Denali Therapeutics Industry Stock Comparison
Sell
47
KRUS
Kura Sushi USA
Last Price:
90.86
Seasonality Move:
26.84%
Buy
68
DNLI
Denali Therapeutics
Last Price:
31.31
Seasonality Move:
6.34%
Sell
47
Kura Sushi USA (KRUS)
is a Sell
Is Kura Sushi USA a Buy, Sell or Hold?
- The current Kura Sushi USA [KRUS] share price is $90.97. The Score for KRUS is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- KRUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $31.35. The Score for DNLI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KRUS Stock Price Chart
What is Kura Sushi USA's stock price today?
-
The Kura Sushi USA share price today is $90.97
The current trend is moderately bearish and KRUS is experiencing selling pressure, which indicates risk of future bearish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $31.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
KRUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.18 | Buy |
Relative Strength Index (14 RSI): | 49.43 | Sell |
Chaikin Money Flow: | -196701 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (84.25 - 98.65) | Sell |
Bollinger Bands (100): | (57.11 - 87.81) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.53 | Buy |
Relative Strength Index (14 RSI): | 68.76 | Buy |
Chaikin Money Flow: | 648733 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.03 - 28.61) | Buy |
Bollinger Bands (100): | (22.45 - 28.23) | Buy |
KRUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 97.58 | Sell |
20-day SMA: | 93.69 | Sell |
50-day SMA: | 83.1 | Buy |
200-day SMA: | 87.3 | Buy |
8-day EMA: | 96.3 | Sell |
20-day EMA: | 93.47 | Sell |
50-day EMA: | 85.54 | Buy |
200-day EMA: | 81.57 | Buy |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.16 | Buy |
20-day SMA: | 27.44 | Buy |
50-day SMA: | 27.75 | Buy |
200-day SMA: | 22.07 | Buy |
8-day EMA: | 28.79 | Buy |
20-day EMA: | 27.93 | Buy |
50-day EMA: | 27.13 | Buy |
200-day EMA: | 23.94 | Buy |
Kura Sushi USA Earnings Growth & KRUS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.19 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.87 per share, and an increase next year of $0.05 per share.
Kura Sushi USA Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |